Investment adviser · CRD 161640
VALENCE LIFE SCIENCES, LLC
Exempt reporting adviser (ERA)
Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.
NEW YORK, NY, United States · Form ADV filed Feb 25, 2020
Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →
Private funds & service providers
7 Private fundsThe count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.
CAXTON ADVANTAGE LIFE SCIENCES FUND, L.P.Venture Capital Fund · Last reported Feb 25, 2020$19.7MGross asset value
Feeder funds
- CAXTON ADVANTAGE LIFE SCIENCES FUND, L.P.
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
PERSHING LLC
SEC 8-17574
Fund details & source
- Fund ID
- 805-3377896422
- Reported beneficial owners
- 12
- Minimum commitment
- $0
- Form D file number
- 021-9999999999
Form ADV 1384928 · Feb 25, 2020 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
VALENCE HELIX INVESTMENTS IIIVenture Capital Fund · Last reported Feb 25, 2020$2.05MGross asset value
No provider names available in this fund's imported disclosure.
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- No
- External marketing
- No
Fund details & source
- Fund ID
- 805-8068988582
- Reported beneficial owners
- 12
- Minimum commitment
- $50K
Form ADV 1384928 · Feb 25, 2020 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
VALENCE HELIX INVESTMENTS IIVenture Capital Fund · Last reported Feb 25, 2020$1.85MGross asset value
No provider names available in this fund's imported disclosure.
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- No
- External marketing
- No
Fund details & source
- Fund ID
- 805-3666762999
- Reported beneficial owners
- 12
- Minimum commitment
- $50K
Form ADV 1384928 · Feb 25, 2020 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
VALENCE HELIX INVESTMENTS IVenture Capital Fund · Last reported Feb 25, 2020$1.65MGross asset value
No provider names available in this fund's imported disclosure.
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- No
- External marketing
- No
Fund details & source
- Fund ID
- 805-9801136954
- Reported beneficial owners
- 10
- Minimum commitment
- $50K
Form ADV 1384928 · Feb 25, 2020 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
VALENCE ADVANTAGE LIFE SCIENCES FUND II, LPVenture Capital Fund · Last reported Jun 7, 2013$59.4MGross asset value
Form D fundraising filings
Valence Advantage Life Sciences Fund II, L.P.
Provider details
- Annual audit
- Yes
- Prime brokers
- Yes
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- Yes
PERSHING LLC
SEC 8-17574
BENEDETTO, GARTLAND & COMPANY, INC.
CRD 24083 · SEC 8-40919
CREDIT SUISSE SECURITIES (USA) LLC
CRD 816 · SEC 8-422
Fund details & source
- Fund ID
- 805-3436476673
- Reported beneficial owners
- 14
- Minimum commitment
- $0
- Form D file number
- 021-174950
Form ADV 741650 · Jun 7, 2013 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
VALENCE CDK SPV, L.P.Other Private Fund · Last reported Feb 23, 2016$10.5MGross asset value
Form D fundraising filings
Provider details
- Annual audit
- No
- Prime brokers
- Yes
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- No
PERSHING LLC
SEC 8-17574
CREDIT SUISSE SECURITIES (USA) LLC
CRD 816 · SEC 8-422
Fund details & source
- Fund ID
- 805-5928487217
- Reported beneficial owners
- 5
- Minimum commitment
- $0
- Form D file number
- 021-213734
Form ADV 979499 · Feb 23, 2016 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
VALENCE ADVANTAGE LIFE SCIENCES SIDE FUND II, LPVenture Capital Fund · Last reported Jun 7, 2013$3.19MGross asset value
Provider details
- Annual audit
- No
- Prime brokers
- Yes
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- No
PERSHING LLC
SEC 8-17574
CREDIT SUISSE SECURITIES (USA) LLC
CRD 816 · SEC 8-422
Fund details & source
- Fund ID
- 805-8053514867
- Reported beneficial owners
- 1
- Minimum commitment
- $0
Form ADV 741650 · Jun 7, 2013 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
Services & filing details
Most recent filing: Feb 25, 2020. View historical filings
Reported services
Not reported in these imported fields
Compensation
Not reported in these imported fields
Principal office
590 MADISON AVENUE, 21ST FLOORNEW YORK, NY, 10022, United States
CRD 161640
Filing source
Form ADV 1384928 · Feb 25, 2020 · Items 1 & 5
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.